UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 323

Sortiert nach

Enhancement of enzymatic fibrinolysis with 2‐MHz ultrasound and microbubbles

Journal of thrombosis and haemostasis, 2004-07, Vol.2 (7), p.1163-1166

2004

Volltextzugriff (PDF)

Laboratory monitoring of low‐molecular‐weight heparin therapy—part II

Journal of thrombosis and haemostasis, 2005-03, Vol.3 (3), p.573-574

BONEU, B.

2005

Volltextzugriff (PDF)

Low molecular weight heparin therapy: is monitoring needed?

Thrombosis and haemostasis, 1994-09, Vol.72 (3), p.330

Boneu, B

1994

Volltextzugriff (PDF)

The specific thromboxane receptor antagonist S18886: pharmacokinetic and pharmacodynamic studies

Journal of thrombosis and haemostasis, 2005-07, Vol.3 (7), p.1437-1445

2005

Volltextzugriff (PDF)

How and When to Monitor a Patient Treated with Low Molecular Weight Heparin

Seminars in thrombosis and hemostasis, 2001-10, Vol.27 (5), p.519-522

2001

Volltextzugriff (PDF)

Platelet anti-aggregating activity and tolerance of clopidogrel in atherosclerotic patients

Thrombosis and haemostasis, 1996, Vol.76 (6), p.939

1996

Volltextzugriff (PDF)

Guidelines of the french society for digestive endoscopy (SFED) : Management of patients on anticoagulants or antiplatelet agents before digestive endoscopy

Endoscopy, 2006-06, Vol.38 (6), p.632-638

2006

Volltextzugriff (PDF)

Long‐haul flights do not activate hemostasis in young healthy men

Journal of thrombosis and haemostasis, 2005-07, Vol.3 (7), p.1539-1541

2005

Volltextzugriff (PDF)

Aging and venous thromboembolism influence the pharmacodynamics of the anti-factor Xa and anti-thrombin activities of a low molecular weight heparin (nadroparin)

Thrombosis and haemostasis, 1998-06, Vol.79 (6), p.1162

1998

Volltextzugriff (PDF)

Pharmacokinetics and tolerance of the natural pentasaccharide (SR90107/Org31540) with high affinity to antithrombin III in man

Thrombosis and haemostasis, 1995-12, Vol.74 (6), p.1468

1995

Volltextzugriff (PDF)

Guidelines of the French Society for Digestive Endoscopy (SFED)

Endoscopy, 2006-06, Vol.38 (6), p.632-638

2006

Volltextzugriff (PDF)

An international multicentre study: Clivarin in the prevention of venous thromboembolism in patients undergoing general surgery. Report of the International Clivarin Assessment Group

Blood coagulation & fibrinolysis, 1993-12, Vol.4 Suppl 1, p.S21-S22

Boneu, B

1993

Volltextzugriff (PDF)

D-Dimers, thrombin antithrombin III complexes and prothrombin fragments 1+2: diagnostic value in clinically suspected deep vein thrombosis

Thrombosis and haemostasis, 1991, Vol.65 (1), p.28

1991

Volltextzugriff (PDF)

Low Molecular Weight Heparins: Are They Superior to Unfractionated Heparins to Prevent and to Treat Deep Vein Thrombosis?

Thrombosis research, 2000-10, Vol.100 (2), p.113-120

Boneu, Bernard

2000

Volltextzugriff (PDF)

D-dimer test and diagnosis of deep vein thrombosis: a comparative study of 7 assays

Thrombosis and haemostasis, 1996-10, Vol.76 (4), p.518

1996

Volltextzugriff (PDF)

Cross-reactivity of human molecular markers for detection of prethrombotic states in various animal species

Blood coagulation & fibrinolysis, 1995-07, Vol.6 (5), p.446-455

1995

Volltextzugriff (PDF)

Inhibition of tissue factor synthesis by disruption of ERK kinases and PKC signaling pathways in human vascular SMCs

Thrombosis and haemostasis, 2000-07, Vol.84 (1), p.129

2000

Volltextzugriff (PDF)

Efficacy and Safety of a Low‐Molecular‐Weight Heparin and Standard Unfractionated Heparin for Prophylaxis of Postoperative Venous Thromboembolism: European Multicenter Trial

World journal of surgery, 1997-01, Vol.21 (1), p.2-9

1997

Volltextzugriff (PDF)

Dermatan sulfate is a more potent inhibitor of clot-bound thrombin than unfractionated and low molecular weight heparins

Thrombosis and haemostasis, 1994-05, Vol.71 (5), p.576

1994

Volltextzugriff (PDF)

Early potent antithrombotic effect with combined aspirin and a loading dose of clopidogrel on experimental arterial thrombogenesis in humans

Circulation (New York, N.Y.), 2000-06, Vol.101 (24), p.2823-2828

2000

Volltextzugriff (PDF)

FREQUENCY OF A DEFECTIVE RESPONSE TO ACTIVATED PROTEIN C IN PATIENTS WITH A HISTORY OF VENOUS THROMBOSIS

Blood, 1994-04, Vol.83 (7), p.2008-2009

1994

Volltextzugriff (PDF)

Anti-thrombotic effect of a synthetic heparin mimetic in an arterial model of thrombosis in rats: comparison with unfractionated heparin and nadroparin

Thrombosis and haemostasis, 2002-10, Vol.88 (4), p.687

2002

Volltextzugriff (PDF)

New antithrombotic agents for the prevention and treatment of deep vein thrombosis

Haemostasis, 1996-01, Vol.26 Suppl 4, p.368

Boneu, B

1996

Volltextzugriff (PDF)

A new method for quantifying platelet deposition in flowing native blood in an ex vivo model of human thrombogenesis

Thrombosis and haemostasis, 1998-01, Vol.79 (1), p.162

1998

Volltextzugriff (PDF)

Prothrombin fragment 1 + 2, thrombin–antithrombin III complexes and D‐dimers in acute deep vein thrombosis: effects of heparin treatment

British journal of haematology, 1991-07, Vol.78 (3), p.421-424

1991

Volltextzugriff (PDF)

1 – 25 von 323

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(249)
Mit Volltextzugriff
(154)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(208)
Science & Technology
(147)
Life Sciences & Biomedicine
(146)
Male
(104)
Biological And Medical Sciences
(102)
Hematology
(101)
Medical Sciences
(85)
Female
(77)
Adult
(76)
Cardiovascular System & Cardiology
(76)
Peripheral Vascular Disease
(76)
Middle Aged
(56)
Animals
(54)
Pharmacology. Drug Treatments
(53)
Blood. Blood Coagulation. Reticuloendothelial System
(50)
Aged
(44)
Rabbits
(37)
Heparin - Pharmacology
(30)
Heparin - Therapeutic Use
(25)
Time Factors
(24)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Enhancement of enzymatic fibrinolysis with 2‐MHz ultrasound and microbubbles

Laboratory monitoring of low‐molecular‐weight heparin therapy—part II

Low molecular weight heparin therapy: is monitoring needed?

The specific thromboxane receptor antagonist S18886: pharmacokinetic and pharmacodynamic studies

How and When to Monitor a Patient Treated with Low Molecular Weight Heparin

Platelet anti-aggregating activity and tolerance of clopidogrel in atherosclerotic patients

Guidelines of the french society for digestive endoscopy (SFED) : Management of patients on anticoagulants or antiplatelet agents before digestive endoscopy

Long‐haul flights do not activate hemostasis in young healthy men

Aging and venous thromboembolism influence the pharmacodynamics of the anti-factor Xa and anti-thrombin activities of a low molecular weight heparin (nadroparin)

Pharmacokinetics and tolerance of the natural pentasaccharide (SR90107/Org31540) with high affinity to antithrombin III in man

Guidelines of the French Society for Digestive Endoscopy (SFED)

An international multicentre study: Clivarin in the prevention of venous thromboembolism in patients undergoing general surgery. Report of the International Clivarin Assessment Group

D-Dimers, thrombin antithrombin III complexes and prothrombin fragments 1+2: diagnostic value in clinically suspected deep vein thrombosis

Low Molecular Weight Heparins: Are They Superior to Unfractionated Heparins to Prevent and to Treat Deep Vein Thrombosis?

D-dimer test and diagnosis of deep vein thrombosis: a comparative study of 7 assays

Cross-reactivity of human molecular markers for detection of prethrombotic states in various animal species

Inhibition of tissue factor synthesis by disruption of ERK kinases and PKC signaling pathways in human vascular SMCs

Efficacy and Safety of a Low‐Molecular‐Weight Heparin and Standard Unfractionated Heparin for Prophylaxis of Postoperative Venous Thromboembolism: European Multicenter Trial

Dermatan sulfate is a more potent inhibitor of clot-bound thrombin than unfractionated and low molecular weight heparins

Early potent antithrombotic effect with combined aspirin and a loading dose of clopidogrel on experimental arterial thrombogenesis in humans

FREQUENCY OF A DEFECTIVE RESPONSE TO ACTIVATED PROTEIN C IN PATIENTS WITH A HISTORY OF VENOUS THROMBOSIS

Anti-thrombotic effect of a synthetic heparin mimetic in an arterial model of thrombosis in rats: comparison with unfractionated heparin and nadroparin

New antithrombotic agents for the prevention and treatment of deep vein thrombosis

A new method for quantifying platelet deposition in flowing native blood in an ex vivo model of human thrombogenesis

Prothrombin fragment 1 + 2, thrombin–antithrombin III complexes and D‐dimers in acute deep vein thrombosis: effects of heparin treatment

Suchergebnisse filtern